| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |